Technology
ScImage Inc. has partnered with Cedaron Medical Inc. to deliver CardiacCare with ScImage’s enterprise picture archive and communications system (PACS), PICOM365.
March 24, 2014
News
Boston Scientific Corp. received CE marking and launched in Europe the Ingevity family of magnetic resonance imaging (MRI) compatible pacing leads. The Ingevity family is a set of leads that can be placed using a 6 French introducer, including passive and active fixation models. Ingevity MRI pacing leads are part of the ImageReady MR-conditional pacemaker system, which includes Vitalio MRI, Formio MRI, Advantio MRI and Ingenio MRI pulse generators. When used with the Latitude NXT patient management system, these devices wirelessly monitor patients for conditions such as atrial arrhythmias.
March 21, 2014
Technology
AccessClosure plans to launch the Mynx Ace Vascular Closure Device at the 2014 American College of Cardiology meeting, March 29-31. It is an upgrade of the company’s Mynx mechanical vascular closure product. It is designed to provide patient comfort and uses an easy-to-use deployment system to seal femoral artery access sites. The device helps reduce time to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures.
March 21, 2014Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025
Case Study
Today, PinnacleHealth is home to one of the foremost transcatheter aortic valve replacement (TAVR) programs in the world. But in the program’s infancy, PinnacleHealth needed to develop relationships between clinicians and facilitate their collaboration using the right diagnostic imaging technology to ensure success. Using a multidisciplinary, collaborative commitment from clinicians and a state-of-the-art hybrid OR lab anchored by Toshiba’s Infinix-i cardiovascular imaging system, PinnacleHealth is improving outcomes for some of its sickest patients. As one of the finest TAVR programs available today, it is also achieving fewer readmissions and lowering costs.
March 19, 2014Feature
Surgeons in France have successfully replaced the aortic valve in two patients without opening the chest during surgery. The procedure, using totally endoscopic aortic valve replacement (TEAVR), shows potential for improving quality of life of heart patients by offering significantly reduced chest trauma. It is described in The Journal of Thoracic and Cardiovascular Surgery.
March 19, 2014
Feature | Dave Fornell
Percutaneous ventricular assist (pVAD) devices offer more hemodynamic support than the 40-year-old gold standard of intra-aortic balloon pumps (IABPs), but their cost and complexity has limited their use to all but the sickest patients. However, the quest for improving patient outcomes and new applications of pVADs for right ventricular support and heart failure indications continues to expand interest in these devices. Several of these new technologies were highlighted in sessions during the 2013 Transcatheter Cardiovascular Therapeutics (TCT) last fall.
March 18, 2014Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024Feature | Dave Fornell
I have watched a trend in medical technology grow from a small ripple a couple years ago into what I expect will be a tidal wave in 2014 due to growing concern over patient radiation dose levels from medical imaging. Use of radiation dose monitoring software came to the forefront when California, followed by Texas, created laws requiring medical facilities to record the amount of exposure patients receive from things like computed tomography (of which cardiac exams are among the highest dose levels used) and angiography. Adoption of this software will be further accelerated by new Joint Commission standards released in December 2013, which starting in mid-2014 requires the use of radiation dose monitoring software as part of its accreditation.
March 18, 2014
News
St. Jude Medical Inc. announced the first enrollments in the company’s LEADLESS Pacemaker Observational Study evaluating the Nanostim leadless pacing technology. The Nanostim pacemaker received CE marking in 2013, and post-approval implants have occurred in the United Kingdom, Germany, Italy, Czech Republic, France, Spain and the Netherlands.
March 18, 2014News
Lumedx Corp. is a provider of vendor-neutral cardiovascular imaging and information systems (CVIS). It announced it has contracted to provide Phoebe Putney Memorial Hospital with a comprehensive CVIS that will integrate patient data and images across five different sites. The Lumedx CVIS will consolidate data, improve physician access to patient information, streamline clinical workflows, and support outcomes analysis and registry reporting for the Phoebe Heart and Vascular Center.
March 18, 2014Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News
Thoratec Corp. initiated a voluntary worldwide Medical Device Correction in order to update its labeling and training materials for the HeartMate II LVAS Pocket System Controller. The following information is provided as a reinforcement of the initial release.
March 18, 2014
News
Patients with coronary artery disease who received an Endeavor or Resolute drug-eluting stent from Medtronic Inc. and subsequently interrupted their dual antiplatelet therapy (DAPT) earlier than current guidelines recommend experienced no increased risk of stent thrombosis at one year or more of follow up. Both devices elute the drug zotarolimus to reduce the risk of restenosis. This is according to findings from several studies presented at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
March 18, 2014
Feature
The increasing number of percutaneous coronary interventions (PCIs) being performed at low-volume centers without on-site cardiac surgery backup has driven the need for new safety and quality protocols. This is according to an expert consensus document written by a committee representing the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA). The document outlines steps hospitals can take to provide the safest possible environment for PCI when the facility does not provide cardiac surgery as a backup should complications occur.
March 18, 2014Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News
Generating new cardiac muscle from human embryonic stem cells (hESCs) and/or induced pluripotent stem cells (iPSC) could fulfill the demand for therapeutic applications and drug testing. The production of a similar population of these cells remains a major limitation, but in a study just published in Stem Cells Translational Medicine, researchers now believe they have found a way to do this.
March 14, 2014
Case Study
Volumes are high at the Bryan Medical Center/Bryan Heart Hospital, located in Lincoln, Neb., resulting in large amounts of data. Managing and monitoring all this data is critical, so the center turned to Lumedx Analytics performance management software. The new solution, staff says, has turned out to be both versatile and powerful.
March 14, 2014
Feature
National Institutes of Health researchers have identified a biological pathway that contributes to the high rate of vein graft failure following bypass surgery. Using mouse models of bypass surgery, they showed that excess signaling via the transforming growth factor beta (TGF-Beta) family causes the inner walls of the vein become too thick. This slows down or sometimes even blocks the blood flow that the graft was intended to restore. Inhibition of the TGF-B signaling pathway reduced overgrowth in the grafted veins.
March 13, 2014